Study of antimicrobial resistance profile and efflux mediated drug resistance in clinical isolates of Pseudomonas aeruginosa detected by ethidium bromide-agar Cartwheel method
DOI:
https://doi.org/10.18203/2320-6012.ijrms20223085Keywords:
Multidrug resistance, Efflux pumps, Ethidium bromide Cartwheel methodAbstract
Background: Development of antibiotic resistance or multidrug resistance (MDR) is one of the major causes of treatment failure of bacterial infections and has rapidly evolved into a threat to global health care. Bacterial efflux pumps play a significant role in the development of antibiotic resistance. This study evaluates the prevalence of efflux pump- mediated drug resistance in clinical isolates of P. aeruginosa.
Methods: Clinical isolates (n=100) of P. aeruginosa were collected from various clinical laboratories in Kerala and their efflux mediated drug resistance detected by the ethidium bromide (EB) agar Cartwheel method.
Results: The EB agar cartwheel method of screening revealed efflux activity in 17% (n=17) strains. The efflux activity was revealed at a minimum concentration of EB at 0 mg/l. P. aeruginosa strains showed the highest activity up to a concentration of 2.5 mg/l.
Conclusions: This study discusses the emergence of efflux pump- mediated drug resistance in P. aeruginosa from various clinical samples. Our results showed that 17% drug resistance in P. aeruginosa is attributable to efflux related mechanisms.
References
Ali Z, Mumtaz N, Naz SA Jabeen N, Shafique M. Multidrug resistant Pseudomonas aeruginosa a threat of nosocomial infections in tertiary care hospitals. J Park Med Assoc. 2015;65:12-6.
Porras Gomez M, Vega baudrit J Snuez correls S. overview of Multidrug resistant Pseudomonas aeruginosa and novel therapeutic approaches. J Biomer Nano Biotechnol. 2012;519-27.
Mahmoud AB, Zahran WA, Hindawi GR, Labib AZ, Galal R. Prevalence of multidrug Resistant Pseudomonas aeruginosa in patients with Nosocomial infections at a university Hospital in Egypt with Special Reference to Typing Methods. J Virol Microbial. 2013;290047.
Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections. Clin Microbiol Rev. 2019;32(4):e00031-19.
Ruiz-Garbajosa P, Cantón R. Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy. Rev Esp Quimioter. 2017;30(1):8-12.
Abdul Hassan HS, El-Tahan KMB, Gomaa R. Bacteriophage therapy of Pseudomonas burn wound sepsis. Ann Medit Burn Club. 1990;262.
Ahmad SI. Treatment of post burns bacterial infections by bacteriophages, specially ubiquitous Pseudomonas spp. Notoriously resistant to antibiotics. Med Hypotheses. 2002;58(4):327-31.
Shigeki F, Moffett KS, Yu VL. Antimicrobe Pseudomonas aeruginosa. Infect Dis Antimicrob Agents. E-Sun Technologies, Inc. 2010-2017.
Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002;34(5):634-40.
Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections. Clin Microbiol Rev. 2019;32(4):e00031-19.
Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22(4):582-610.
Langendonk RF, Neill DR, Fothergill JL. The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies. Front Cell Infect Microbiol. 2021;11:665759.
Hancock RF. Resistance mechanisms in Pseudomonas aeruginosa and other non- fermentative gram negative bacteria. Clin infect Dis. 1998;27.
Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence. 2013;4(3):223-9.
Dreier J, Ruggerone P. Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa. Front Microbiol. 2015;6:660.
Martins M, Viveiros M, Couto I, Costa SS, Pacheco T, Fanning S, Pagès JM, Amaral L. Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method. In Vivo. 2011;25(2):171-8.
Martins M, McCusker MP, Viveiros M, Couto I, Fanning S, Pagès JM, Amaral L. A Simple Method for Assessment of MDR Bacteria for Over-Expressed Efflux Pumps. Open Microbiol J. 2013;7:72-82.
Merchant S, Proud foot EM, Quari HN, Mc Elroy HJ,Wright WR, Gupta A Sarpong EM. Risk factors for Pseudomonas aeruginosa infections in Asia- Pacific and consequences of in appropriate initial antimicrobial therapy: A systematic literature review and meta-analysis. J Glob Antimicrob Resist. 2018;14:33-44.
Neuhauser MM, Weistein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA. 2003;289(7):885-8.
Golia S, Suhani, Manasa S, Jyoti. Isolation of P. aeruginosa from various clinical isolates and it Antimicrobial Resistance Pattern in a Tertiary Care Hospital. Int J Curr Microbiol App Sci. 2016;5(3):247-53.
Oladipo EK, Oloke JK, Omomowo IO, Oyeniran AO, Awoyelu EH, Ogundele SO. Incidence of Cephalosporins resistance among clinical isolates of P. aeruginosa in Ibadan, South Western Nigeria. Int J Med BioMed Res. 2015;4(3).
Javiya VA, Ghatak SB, Patel KR, Patel JA. Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India. Indian J Pharmacol. 2008;40(5):230-4.
Sreekanth B, Suresh G, Deepthy BJ, Saleel VM, Harish PV. Antibiotic profile pf P.aeruginosa strains isolated from various clinical specimens in DM WIMS hospital Wayanad, Kerala. J Evol Med Dent Sci. 2014;3(19):5090-3.
Sun YT, Deng YX, Kwapong WR, Ma LX. Clinical distribution, drug resistance and risk factor analysis of P. aeruginosa infections. In J Clin Exp Med 2019;12(10):12322-30.
Hamal D, Bhatt DR, Shrestha R, Supram HS, Nayak N, Gokhale S, et al. Changing trends in antibiotic susceptibility pattern among clinical isolates of Pseudomonas species in a tertiary care hospital in Nepal. Ann Clin Chem Lab Med. 2021;4(1).
Sharpiro HM. Flow cytometry of bacterial membrane potential and permeability. Methods Mol Med. 2008;142:175-86.
Aszalos A. Drug drug interactions affected by the transporter protein, P-glycoprotein (ABCBI, MDRI)I. P reclinical aspects. Drug Discov Today. 2007;12;833-7.
Viverios M, Martins A, Rodrigues L, Mrtins M, Couto I, et al. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG I00 by an automated ethidium bromide method. Int J Antimicrob Agents. 2008;31;458-62.
Kyriacou SV, Nowak ME, Browlow WJ, Xuxhn. Single live cell imaging for real time monitoring of resistance mechanism in Pseudomonas aeruginosa. J Biomed Opt. 2002;7:576-86.
Duffy L, Dykes GA. Growth temperature of four Campylobactor jejuni strains influences their subsequent survival in food and water. Lett Appl Microbiol. 2006;43;596-601.
Manju S, Nithya N, Jayasree PR, Manish Kumar PR. Detection and prevalence of efflux pump mediated drug resistance in clinical isolates of multidrug resistance gram negative bacteria from north Kerala, India. Pharm Clin Res. 2016;9(3).
